Attenuation of ventilator-induced acute lung injury in an animal model by inhibition of neutrophil adhesion by leumedins (NPC 15669)

Autor: Desmond Bohn, Ernest Cutz, Ludwik Fedorko, Peter C. Rimensberger
Jazyk: angličtina
Rok vydání: 1998
Předmět:
Neutrophils
Leucine/analogs & derivatives/pharmacology
Intercellular Adhesion Molecule-1
CD18
Lung injury
Critical Care and Intensive Care Medicine
Positive-Pressure Respiration
Random Allocation
Oxygen/blood
Leucine
Intensive care
Cell Adhesion
Tidal Volume
Medicine
Animals
Cell Adhesion/drug effects
Lung
Lung Compliance
Peroxidase
Respiratory Distress Syndrome
ddc:618
biology
business.industry
Cell adhesion molecule
Pulmonary Gas Exchange
Respiratory disease
Anti-Inflammatory Agents
Non-Steroidal

Neutrophils/drug effects/physiology
Intercellular Adhesion Molecule-1/analysis
Anti-Inflammatory Agents
Non-Steroidal/pharmacology

medicine.disease
Respiration
Artificial/adverse effects

Respiration
Artificial

Immunohistochemistry
Respiratory Distress Syndrome
Adult/etiology/metabolism/pathology/physiopathology

Oxygen
medicine.anatomical_structure
Integrin alpha M
Lung/metabolism/pathology
Immunology
biology.protein
Rabbits
business
Peroxidase/metabolism
Zdroj: Critical Care Medicine, Vol. 26, No 3 (1998) pp. 548-55
ISSN: 0090-3493
Popis: Beta2-integrin (CD11b/CD18) expression, an indicator of neutrophil activation, has been associated with the development of acute respiratory distress syndrome. Leumedins act directly on leukocytes to inhibit the up-regulated expression of beta2-integrins involved in leukocyte adhesion. We examined the effect of such a new anti-inflammatory agent, NPC 15669 (N-[9H-(2,7-dimethylfluorenyl-9-methoxy)-carbonyl]-L-leucine), on neutrophil-mediated acute lung injury in an animal model.Prospective, randomized, blinded, controlled animal study.An animal laboratory in a university setting.Adult New Zealand rabbits.After repeated lung lavages with normal saline to induce acute lung injury, anesthetized rabbits were randomly assigned to one of two groups (n = 6 per group): a) treatment group (pretreated with NPC 15669 [10 mg/kg i.v. bolus] 30 mins before lavage, followed by a continuous infusion [5 mg/kg/hr] for the duration [4 hrs] of the experiment); or b) control group (pretreatment and continuous infusion with placebo). All animals were mechanically ventilated with identical pressure settings over 4 hrs and were killed at the end of the experiment.PaO2, PaCO2, and tidal volumes were repeatedly measured and airway pressure settings were noted every 30 mins. At the end of the experiment, lungs were taken out for measurements of the myeloperoxidase content, for conventional histology (hematoxylin and eosin staining), and for intracellular adhesion molecule-1 immunohistostaining. Pretreatment with NPC 15669 profoundly improved oxygenation from a PaO2 of 52 +/- 5 torr (6.9 +/- 0.7 kPa) to 250 +/- 161 torr (33.3 +/- 21.5 kPa) within 60 mins after lung lavage (p.05). Oxygenation continued to improve throughout the study, reaching a maximal PaO2 value of 395 +/- 98 torr (52.7 +/- 13.1 kPa) at 4 hrs. In the control group, oxygenation remained poor throughout the observation period. PaO2 values differed significantly (51 +/- 20 torr [6.8 +/- 2.7 kPa] vs. 306 +/- 126 torr [40.8 +/- 16.8 kPa], p.005) at 90 mins and at all subsequent measurements from those values in the NPC 15669 group. Dynamic lung compliance improved significantly 60 to 90 mins after repeated lung lavage. Histology demonstrated markedly less lung damage (hyaline membrane formation and leukocyte infiltration) in treated animals (p.05) than in controls.NPC 15669 seems to block inflammatory reactions by inhibiting the sequestration of neutrophils in acute, ventilator-associated lung injury. As a result, gas exchange and total lung compliance improve. Application of this and similar compounds affecting neutrophil adhesion warrants further investigation as a treatment modality for acute lung injury.
Databáze: OpenAIRE